Korea Investment Corp
AGN

Korea Investment Corp’s Allergan Inc AGN Stock Holding History

Korea Investment Corp’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-268,200
Closed -$57M – 651
2014
Q4 		$57M Sell
268,200
-14,500
-5% -$2.88M 0.47% 41
2014
Q3 		$50.4M Sell
282,700
-5,800
-2% -$963K 0.41% 46
2014
Q2 		$48.8M Buy
288,500
+57,300
+25% +$8.92M 0.41% 49
2014
Q1 		$28.7M Sell
231,200
-56,200
-20% -$6.84M 0.25% 93
2013
Q4 		$31.9M Sell
287,400
-260,100
-48% -$24.8M 0.3% 79
2013
Q3 		$49.5M Buy
547,500
+384,300
+235% +$34.5M 0.53% 39
2013
Q2 		$13.7M Buy
+163,200
New +$16.9M 0.16% 130

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Korea Investment Corp's AGN Position: Q1 2015 in Review

Korea Investment Corp sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 268,200 shares — an estimated $57M sold.

Korea Investment Corp first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $57M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Korea Investment Corp reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Korea Investment Corp sold 268,200 Allergan Inc shares in Q1 2015, an estimated $57M.
  • Korea Investment Corp first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Korea Investment Corp's Allergan Inc position peaked at $57M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Korea Investment Corp's 13F filing for Q1 2015, filed 11 May 2015.